DE3001797A1 - Indoprofen-arzneimittel mit kontinuierlicher freigabe und verfahren zu seiner herstellung - Google Patents

Indoprofen-arzneimittel mit kontinuierlicher freigabe und verfahren zu seiner herstellung

Info

Publication number
DE3001797A1
DE3001797A1 DE19803001797 DE3001797A DE3001797A1 DE 3001797 A1 DE3001797 A1 DE 3001797A1 DE 19803001797 DE19803001797 DE 19803001797 DE 3001797 A DE3001797 A DE 3001797A DE 3001797 A1 DE3001797 A1 DE 3001797A1
Authority
DE
Germany
Prior art keywords
indoprofen
cellulose ether
microencapsulated
tablets
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19803001797
Other languages
German (de)
English (en)
Inventor
Abu Shafiul Alam
Herman Joseph Eichel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Adria Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adria Laboratories Inc filed Critical Adria Laboratories Inc
Publication of DE3001797A1 publication Critical patent/DE3001797A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19803001797 1979-01-25 1980-01-18 Indoprofen-arzneimittel mit kontinuierlicher freigabe und verfahren zu seiner herstellung Withdrawn DE3001797A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US697179A 1979-01-25 1979-01-25

Publications (1)

Publication Number Publication Date
DE3001797A1 true DE3001797A1 (de) 1980-08-07

Family

ID=21723530

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19803001797 Withdrawn DE3001797A1 (de) 1979-01-25 1980-01-18 Indoprofen-arzneimittel mit kontinuierlicher freigabe und verfahren zu seiner herstellung

Country Status (6)

Country Link
JP (1) JPS55100314A (enExample)
CA (1) CA1136548A (enExample)
DE (1) DE3001797A1 (enExample)
FR (1) FR2447192A1 (enExample)
GB (1) GB2041222B (enExample)
IT (1) IT1129713B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0436729A4 (en) * 1989-08-01 1991-09-11 Kanebo, Ltd. Microcapsule, treatment liquid containing microcapsules, and textile structure having microcapsules stuck thereto

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57209223A (en) * 1981-06-19 1982-12-22 Tanabe Seiyaku Co Ltd Microcapsule for intracranial anti hypotension and its production
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
IL95423A (en) * 1989-09-21 1994-11-11 American Cyanamid Co Pulsatile once-a-day delivery systems for minocycline
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
US5262173A (en) * 1992-03-02 1993-11-16 American Cyanamid Company Pulsatile once-a-day delivery systems for minocycline

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155590A (en) * 1962-08-02 1964-11-03 Ncr Co Encapsulation process and its product
US3557279A (en) * 1969-06-12 1971-01-19 Merck & Co Inc Microencapsulation form of an anti-inflammatory drug
JPS5432614A (en) * 1977-08-11 1979-03-10 Tanabe Seiyaku Co Ltd Preparation of microcapsules containing pharmaceuticals

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0436729A4 (en) * 1989-08-01 1991-09-11 Kanebo, Ltd. Microcapsule, treatment liquid containing microcapsules, and textile structure having microcapsules stuck thereto

Also Published As

Publication number Publication date
FR2447192A1 (fr) 1980-08-22
GB2041222B (en) 1983-05-11
GB2041222A (en) 1980-09-10
CA1136548A (en) 1982-11-30
JPS55100314A (en) 1980-07-31
IT1129713B (it) 1986-06-11
IT8019430A0 (it) 1980-01-24
FR2447192B1 (enExample) 1983-08-19

Similar Documents

Publication Publication Date Title
DE69422861T2 (de) Pharmazeutische Zusammensetzung mit kontrollierter Freigabe auf Grund von einer oder mehrerer pharmazeutischer verträglicher Salze von Gamma-Hydroxybuttersäure
AT398165B (de) Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung mit verzögerter wirkstofffreisetzung bzw. kombinierter verzögerter/rascher wirkstofffreisetzung
DE69717312T2 (de) Intestinale absorption von nikotin für die behandlung von nikotinabhängigen zustanden
US4316884A (en) Sustained release pharmaceutical formulation
DE3852877T2 (de) Pharmazeutische Zubereitungen zur Verhütung von Arzneimitteltoleranz.
DE60005819T2 (de) Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
DE69018647T2 (de) Arzneimittel.
DE69727922T2 (de) Schnell zerfallende orale dosierungsform
DE3538429C2 (de) Pulver mit gesteuerter Freisetzung, Verfahren zu dessen Herstellung und dessen Verwendung
DE3587274T2 (de) Dosierungsform eine vielzahl mit einer diffusionshuelle ueberzogener einheiten enthaltend.
EP0864326B1 (de) Mehrphasige wirkstoffhaltige Zubereitungsformen
EP0299211B1 (de) DHP-Manteltablette
DE69128569T2 (de) Tablette mit verzögerter Wirkstoffabgabe
DE69829591T2 (de) Fenofibrathaltige Suspension in einer hydrophilen Polymerlösung
DE3853566T2 (de) Formulierungen von Tetrazyklinverbindungen mit kontrollierter Freisetzung.
DE69508385T2 (de) Gegen missbrauch geschuetzte tabletten
EP0955041B1 (de) Wässrige Dispersion geeignet zur Herstellung von Überzugs- und Bindemitteln für feste orale Arzneiformen
DE69735644T2 (de) Nateglinide zubereitung in tablettenform
DE69117922T2 (de) Zusammensetzungen gegen malaria
CH668553A5 (de) Arzneimittel mit verzoegerter wirkstofffreisetzung.
DE3218059C2 (de) Verfahren zur Herstellung von Ethylzellulose-Mikrokapseln
EP0250648B1 (de) Pharmazeutisches Präparat zur verzögerten Freigabe von Ibuprofen
DE19733505A1 (de) Schnell wirksames Analgeticum
WO2001091729A1 (de) Formulierung auf heparin-, glycosaminoglykan- oder heparinoidbasis und verwendung der formulierung sowie der formulierungsgrundlage
EP0339420B1 (de) DHP-Retard-Zubereitung

Legal Events

Date Code Title Description
8128 New person/name/address of the agent

Representative=s name: MUELLER-BOERNER, R., DIPL.-ING., 1000 BERLIN WEY,

8139 Disposal/non-payment of the annual fee